NasdaqGM:EDAPMedical Equipment
Persistent €19.6 Million Annual Loss Tests EDAP TMS (NasdaqGM:EDAP) Growth Narrative After Q3 Results
EDAP TMS (NasdaqGM:EDAP) has reported Q3 2025 revenue of €13.9 million, with a basic EPS loss of €0.13 and net income loss of €5.0 million, while the trailing twelve months show revenue of €63.8 million, basic EPS loss of €0.52 and a net income loss of €19.6 million. Over recent quarters, the company has reported revenue of €13.1 million in Q3 2024, €20.3 million in Q4 2024 and €16.0 million in Q2 2025. Quarterly EPS losses have ranged from €0.05 in Q4 2024 to €0.19 in Q1 2025. This...